Award
NIH Reporter #3R01CA276846-03S1
Preventing invasive prostate cancer
Recipient
University of Nebraska Medical Center, Omaha, NE, United States
Award Amount
$138,214.00
Ceiling
$138,214.00
Awarded
September 18, 2025
Identifier
3R01CA276846-03S1
A research project funded by the National Cancer Institute to test a novel drug that inhibits prostate cancer cell movement to prevent metastasis and deadly spread.
Description
This project aims to identify and validate the pharmacologic binding site of the agent KBU2046, characterize the signaling pathway involved in prostate cell motility, and evaluate the targeting of motility in relevant models of human disease. The research has high potential for cancer prevention and interception, applicable to many cancer types.